Keyron Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 18

Keyron General Information

Description

Developer of a clinical-stage medical technology platform designed to provide incision-free and reversible metabolic intervention for people with severe obesity and metabolic disease. The company's platform offers a non-invasive, fully reversible approach that replicates the metabolic benefits of bariatric procedures, enabling patients seeking alternatives to medication and invasive surgery to access improved treatment options.

Contact Information

Website
www.keyron.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 103c Camley Street
  • King's Cross
  • London N1C 4PF
  • England, United Kingdom
+44 07975
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Corporate Office
  • 103c Camley Street
  • King's Cross
  • London N1C 4PF
  • England, United Kingdom
+44 07975

Keyron Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keyron Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) $7.5M In Progress Pre-Clinical Trials
5. Later Stage VC 02-Feb-2026 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
3. Later Stage VC (Series A) 08-Feb-2023 Cancelled Generating Revenue
2. Seed Round 17-Aug-2021 $954K $1.82M Completed Generating Revenue
1. Angel (individual) 27-Feb-2019 $870K $870K Completed Startup
To view Keyron’s complete valuation and funding history, request access »

Keyron Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
A Ordinary
Ordinary 10,185 $0.000138 $35.74 $35.74 1x $35.74 6.87%
To view Keyron’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Keyron Patents

Keyron Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230049289-A1 Orally administrable intragastric balloon Inactive 21-Feb-2020
WO-2021165899-A1 Orally administrable intragastric balloon Inactive 21-Feb-2020
AU-2017335310-A1 Expandable intragastric device Active 28-Sep-2016
AU-2017335310-B2 Expandable intragastric device Active 28-Sep-2016
EP-3518839-A1 Expandable intragastric device Active 28-Sep-2016 A61F5/003
To view Keyron’s complete patent history, request access »

Keyron Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keyron Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Lobi Holdings ApS Corporation Minority
Angel (individual) Minority
Medeor Associates Growth/Expansion Minority
You’re viewing 5 of 18 investors. Get the full list »

Keyron FAQs

  • When was Keyron founded?

    Keyron was founded in 2016.

  • Where is Keyron headquartered?

    Keyron is headquartered in London, United Kingdom.

  • What is the size of Keyron?

    Keyron has 8 total employees.

  • What industry is Keyron in?

    Keyron’s primary industry is Therapeutic Devices.

  • Is Keyron a private or public company?

    Keyron is a Private company.

  • What is Keyron’s current revenue?

    The current revenue for Keyron is .

  • How much funding has Keyron raised over time?

    Keyron has raised $3.55M.

  • Who are Keyron’s investors?

    , , Lobi Holdings ApS, , and Medeor Associates are 5 of 18 investors who have invested in Keyron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process